Koers Cryo-Cell International, Inc. Other OTC
Aandelen
CCEL
US2288951088
Gezondheidszorgvoorzieningen & -diensten
Omzet 2024 * | 31,78 mln. 29,61 mln. | Omzet 2025 * | 35,21 mln. 32,81 mln. | Marktkapitalisatie | 69,46 mln. 64,72 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - 0 | Nettowinst (verlies) 2025 * | 1 mln. 932K | EV/omzet 2024 * | 2,19 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 1,97 x |
K/w-verhouding 2024 * |
286
x | K/w-verhouding 2025 * |
71,4
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 26,32% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mark Portnoy
CEO | Chief Executive Officer | 60 | 01-08-11 |
David Portnoy
CEO | Chief Executive Officer | 61 | 01-08-11 |
Jill Taymans
DFI | Director of Finance/CFO | 55 | 01-04-97 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Portnoy
CEO | Chief Executive Officer | 61 | 01-08-11 |
Mark Portnoy
CEO | Chief Executive Officer | 60 | 01-08-11 |
Harold Berger
BRD | Director/Board Member | 60 | 25-08-11 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+14,10% | 81,84 mld. | |
-30,15% | 70,69 mld. | |
+9,37% | 29,03 mld. | |
-11,90% | 16,97 mld. | |
-0,36% | 16,83 mld. | |
-1,12% | 15,28 mld. | |
+5,90% | 12,41 mld. | |
+35,78% | 12,26 mld. | |
-4,20% | 11,86 mld. |